that characterized lysosome-targeting chimeras, or LYTACs.
This new class of molecules bind both the extracellular domain of a target protein and a cell-surface receptor involved in the lysosomal degradation pathway. In the presence of a LYTAC, the activated M6PR tags and drags the target protein to its degradation.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
CarolynBertozzi LyciaTx Palleon_Pharma CatalentPharma Quite literally the best definition of 'over-achiever' I've ever seen. good job to her!